Background: Eosinophils are a subset of granulocytes that can be involved in the pathogenesis of different diseases, including allergy. Their effector functions are closely linked to their cytotoxic granule proteins. Release takes place through several different mechanisms, one of which is cytolysis, which is associated with release of intact granules, so-called clusters of free eosinophil granules. The mechanism underlying this activation-induced form of cell death in eosinophils has remained unclear. Objective: We aimed to elucidate the molecular mechanism of eosinophil cytolysis. Methods: Isolated blood eosinophils were incubated on glass coverslips coated with intravenous immunoglobulin and inactive complement component 3b. A morphologic characterization of the distinct stages of the proposed cascade was addressed by means of time-lapse automated fluorescence microscopy, electron microscopy, and immunohistochemistry. Experiments with pharmacologic inhibitors were performed to elucidate the sequence of events within the cascade. Tissue samples of patients with eosinophilic skin diseases or eosinophilic esophagitis were used for in vivo analyses. Results: After eosinophil adhesion, we observed reactive oxygen species production, early degranulation, and granule fusion processes, leading to a distinct morphology exhibiting
Eosinophils are a subset of granulocytes found in increased numbers in both inflamed tissues and peripheral blood under different pathologic conditions, such as allergy, parasitic infections, and autoimmune and neoplastic diseases. 1 Eosinophils contain granules, which are made up of highly cytotoxic granule proteins that have been linked to destruction of too-large-to-phagocytose pathogens, such as helminths. Early studies highlighted the potential of eosinophils to lyse IgG-and/or complement-coated Schistosoma mansoni in vitro, 2 whereby the presence of complement enhanced the eosinophilmediated cytotoxicity. 3 Addition of the calcium ionophore A23187 to eosinophils also induced stable adhesion and degranulation, resulting in damage to schistosomula. 2 Transmission electron microscopy (TEM) revealed granule release through large cytoplasmic vacuoles on treatment of eosinophils with A23187. 4 Cytolysis, a nonapoptotic form of eosinophil death, 5 was also described as the mechanism underlying A23187-induced degranulation. 6 Whether eosinophil vacuolization and cytolysis are functionally linked or separate and independent degranulation processes has remained unknown.
Cytolysis is characterized by cytoplasmic membrane disintegration 6 and release of intact granules, which accumulate as clusters of free eosinophil granules (cfegs) in the extracellular space. 7 Release of free granules correlated with epithelial cell damage on allergen challenge in guinea pig models of asthma. 8 Moreover, the presence of cfegs, eosinophil vacuolization, and cytolysis has been linked to the severity of asthma exacerbation in children. 9 These findings support the hypothesis of a crucial role of eosinophil vacuolization and cytolysis for eosinophil-driven diseases.
Although the presence of cytolytic eosinophils and cfegs in eosinophilic tissues has been described under various in vivo conditions, 10, 11 the mechanisms leading to cell death and granule release are still largely unknown. Recently, it has been reported that eosinophil cytolysis is mediated by an NADPH oxidase-dependent and caspase-independent cell death characterized by extracellular DNA trap formation. 12 In the present study we have investigated morphologic changes and biochemical pathways leading to eosinophil cytolysis and propose that it is a form of regulated necrosis, most likely necroptosis, 13 because the death process depends on receptorinteracting protein kinase 3 (RIPK3) and mixed lineage kinase-like (MLKL) protein. Interestingly, prior pharmacologic activation of autophagy counterregulates eosinophil cytolysis. Thus inhibiting the RIPK3-MLKL pathway and stimulating autophagy in eosinophils represent 2 new ideas as therapeutic strategies for preventing eosinophil-mediated tissue damage.
METHODS Cells
Human blood eosinophils from healthy subjects were isolated, as described previously.
14 Briefly, cell separation was performed by using Ficoll-Hypaque centrifugation (Seromed-Fakola AG, Basel, Switzerland). The granulocyte fraction was depleted of erythrocytes by means of lysis with a buffer containing NH 4 Cl, KHCO 3 , and EDTA. Eosinophil separation from neutrophils was achieved by means of CD16 2 selection with the human eosinophil enrichment kit (Miltenyi Biotec, Bergisch Gladbach, Germany). The morphology of eosinophils was assessed by means of staining with Diff-Quik (Baxter, D€ udingen, Switzerland) and light microscopic analysis. The purity of the isolated human eosinophil populations was always greater than 95%. Eosinophil morphology was also analyzed in Diff-Quik-stained blood smears obtained from 20 healthy donors and 20 patients with hypereosinophilic syndrome (HES). Written informed consent was obtained from all blood donors, and the Ethics Committee of the Canton Bern had approved the study previously.
Cell cultures
Eosinophils were cultured at 1 3 10 6 /mL in culture medium (RPMI 1640 plus GlutaMAX [Invitrogen, Carlsbad, Calif] supplemented with penicillin/ streptomycin and different concentrations of heat-inactivated FCS). Two systems were used to induce cytolysis. In initial experiments we cultured eosinophils for the indicated times on naked glass coverslips in culture medium containing 0.5% FCS. In most experiments, however, we specifically stimulated eosinophils with intravenous immunoglobulin (IVIG) plus inactive complement component 3b (iC3b) in culture medium containing 5% FCS. In some experiments eosinophils were additionally stimulated with 25 ng/mL IL-5. Briefly, glass coverslips were coated with 10 mg/mL IVIG overnight at 48C. After 3 washing steps, 10 mg/mL iC3b was added at 378C for 1 hour. On further washing steps, the reaction was stopped with addition of 1% BSA to each well. Single-coated (10 mg/mL IVIG or 10 mg/mL iC3b) and 1% BSA-coated coverslips served as controls. Freshly isolated blood eosinophils were hereupon cultured on coated coverslips in culture medium containing 5% FCS at 378C for indicated times in a humidified atmosphere containing 5% CO 2 . Cells were then morphologically examined by staining with Diff-Quik and light microscopic analysis (Axiovert 35; Carl Zeiss Micro Imaging, Jena, Germany). Alternatively, we stained cells with 0.4 mmol/L calcein-AM, 1 mg/mL Hoechst 33342, 1 mmol/L DHR 123, and 0.1 mmol/L ethidium homodimer 1 (Invitrogen) and followed cells by using time-lapse automated fluorescence microscopy (LSM 510 Exciter, Carl Zeiss Microimaging). For mechanistic studies, we cultured eosinophils in the presence of 5 mg/mL anti-CD18 F(ab9) 2 fragments, as well as 100 nmol/L wortmannin, 10 mmol/L PD169316, 1 mmol/L diphenyleneiodonium chloride (DPI), 10 mmol/L necrostatin 1 (Nec-1), 20 mmol/L z-VAD-fmk (z-VAD), 50 mmol/L GSK9843, 10 mmol/L GSK9872, 5 mmol/L GW806742X, and 5 mmol/L rapamycin. For Nec-1, GSK9843, GSK9872, and GW806742X, we performed concentration-dependent experiments to determine the optimal inhibitory concentration. Preincubations with antibodies and pharmacologic inhibitors, respectively, were performed for 30 minutes. Anti-TNF receptor (TNFR) 1 (10 mg/mL), anti-TNFR2 (10 mg/mL), and anti-TNF-a (5 mg/mL) mAbs were added 90 minutes before IVIG plus iC3b activation to test for TNFa-mediated effects.
Confocal laser scanning microscopy
Eosinophils were fixed with 4% paraformaldehyde for 5 minutes, washed with PBS (pH 7.4), and subsequently permeabilized with 0.05% saponin in PBS (pH 7.4) for 5 minutes at room temperature (RT) and acetone for 10 minutes at 2208C. For analysis of phospho-MLKL expression, eosinophils were fixed with acetone only, and staining was performed in the presence of 0.01% saponin. Nonspecific binding was prevented by means of preincubation of adherent cells with a blocking buffer (containing human immunoglobulins, normal goat serum, and 7.5% BSA) at RT for 1 hour. Subsequently, indirect immunofluorescence staining was performed, as previously described, 15 by using primary antibodies diluted in blocking solution (48C overnight), as well as subsequent appropriate fluorescein isothiocyanate-or Cy3-conjugated secondary antibodies (RT for 1 hour). Propidium iodide (PI), Hoechst 33342 (both for nuclear staining), or CellTracker Red (for cellular staining) were added for an additional 10 minutes. Staining with cellpermeable fluorescent dyes, such as AUTOdot (Abgent, San Diego, Calif), Syto 13, CellTracker Red, and MitoSOX (all: Invitrogen, Camarillo, Calif), or with the cell membrane dye PKH67 (Sigma-Aldrich, Buchs, Switzerland) were performed on live cells before fixation, according to the corresponding manufacturer's instructions. As primary antibodies, anti-MLKL (phospho S358; 1:250), anti-eosinophil cationic protein (5 mg/mL), and anti-eosinophil peroxidase (EPX) mAbs (1 mg/mL) were used. Mouse or rabbit isotype controls served as staining controls and were used at the corresponding concentrations, and cells were stained with secondary antibody only. Staining analysis was performed with the confocal laser scanning microscopes LSM 510 and LSM 5 Exciter (Carl Zeiss Microimaging). C-sections were performed at the resolution limit to produce a high-resolution stack for subsequent 3-dimensional reconstruction. Transmitted light was used to determine the corresponding morphology within the process of cytolysis. The percentage of vacuolated eosinophils in patients with eosinophil-associated skin diseases was determined in a total area of 0.087 mm 2 . Eosinophil vacuolization and MLKL phosphorylation in tissues was also analyzed by means of indirect immunofluorescence after staining of indicated eosinophilic tissues with anti-eosinophil cationic protein (5 mg/mL), anti-EPX (1 mg/mL), and anti-MLKL (phospho-S358; 1:250) mAbs, as previously described. [16] [17] [18] Oxidative burst measurements Eosinophils (1 3 10 6 /mL in RPMI 1640 plus 5% FCS) were pretreated with the indicated pharmacologic inhibitors and antibodies, respectively, in Eppendorf tubes for 20 minutes in a CO 2 incubator at 378C. DHR 123 (1 mmol/L) was added to each Eppendorf tube for the last 10 minutes of incubation. One hundred microliters of cell suspension was added to each well by using black, glass-bottom, 96-well plates (Greiner Bio-One GmbH, Frickenhausen, Germany) previously coated with IVIG plus iC3b and kept at 378C. Fluorescent activity of the DHR 123 dye was immediately measured at excitation of 502 nm and fluorescence emission intensity of 530 nm by using a spectrofluorometer (SpectraMax M2; Molecular Devices, Biberach an der Riß, Germany). The kinetics of superoxide production were timedependently analyzed every 5 minutes at 378C up to 1 hour. Relative DHR 123 fluorescence was obtained on subtraction of the corresponding DHR 123 fluorescence of medium without cells at the corresponding time point and subsequent norming of the values to initially measured fluorescence. Cells added to 1% BSA-coated wells served as negative controls, and 25 nmol/L phorbol 12-myristate 13-acetate (PMA)-stimulated cells served as positive controls. 19 Reactive oxygen species (ROS) production in single eosinophils was analyzed by using time-lapse automated fluorescence microscopy (see the description of additional Methods in this article's Online Repository at www.jacionline.org).
Statistical analysis
Data were analyzed with GraphPad Prism 5 software (GraphPad Software, La Jolla, Calif). Figures depict means 6 SEMs, and the numbers of independent experiments performed are provided in the figure legends. Oneway ANOVA, followed by the Tukey multiple comparison test or the KruskalWallis test, was applied. P values of less than .05 were considered statistically significant.
RESULTS

Adhesion to IVIG plus iC3b results in eosinophil cytolysis
To address morphologic and molecular events in the process of eosinophil cytolysis, we first applied a nonspecific adhesion system in which the reduction of FCS content in the medium of cultured eosinophils from 5% to 0.5% evoked vacuolization and, in approximately 20% of cells, lysis with dispersion of nuclear material within 1 hour (Fig 1, A, upper left panel). Pretreatment of the glass surface with poly-2-hydroxyethyl methacrylate (PolyHema), an antiadhesive substratum, 20 prevented this cytolysis (Fig 1, A, upper right panel), suggesting that adhesion, but not
Eosinophil cytolysis is induced on adhesion to naked glass, as well as IVIG plus iC3b-coated glass. A, Upper left, Untreated freshly isolated human eosinophils were added to glass coverslips in low FCS-containing culture medium and stained with Diff-Quik. Cytoplasmic vacuolization and necrotic cell death, which is characterized by deposition of eosinophil granules (rhombus) and nuclear disintegration (arrowhead), were observed. Upper right, Preventing adhesion with poly-2-hydroxyethyl methacrylate (Poly-Hema) resulted in an unchanged eosinophil morphology during the entire culture period. Lower left, Enzymatic inactivation of caspases with z-VAD did not prevent the necrotic morphology. Lower right, Eosinophil adhesion to IVIG plus iC3b-coated glass also provoked cytoplasmic vacuolization and necrotic cell death. Bars 5 10 mm. Data are representative of at least 3 independent experiments. B, Eosinophil adhesion to IVIG plus iC3b-coated glass-provoked cell death, as assessed by using live cell imaging. Interestingly, additional stimulation with IL-5 resulted in accelerated eosinophil death. Values are means 6 SEM. **P < .01 and ****P < .0001 (n 5 3). See also Fig E1 and associated Video E1. Right, TEM images of the necrotic eosinophils showed plasma and nuclear membrane disruption (upper panel), release of entire granules, and the typical cfegs (lower panel).
Bars 5 1 mm. C, Blocking of CD18 with F(ab9) 2 fragments of anti-CD18 mAb largely prevented eosinophil spreading as quantified 5 minutes after initiation of IVIG plus iC3b stimulation. Values are means 6 SEM. **P < .01 (n 5 5). D, Blocking of CD18 with F(ab9) 2 fragments of anti-CD18 mAb largely prevented cytoplasmic vacuolization, as quantified 15 minutes after initiation of IVIG plus iC3b stimulation. Values are means 6 SEMs. **P < .01 (n 5 5). E, Blocking of CD18 with F(ab9) 2 fragments of anti-CD18 mAb largely prevented eosinophil death quantified 1 hour after initiation of IVIG plus iC3b stimulation. Values are means 6 SEMs. ****P < .0001 (n 5 5). = starvation, is critical in initiation of the death process. Pharmacologic inhibition of caspases did not prevent eosinophil cytolysis (Fig 1, A, lower left panel).
Because eosinophil-mediated lysis of S mansoni was reported to be more efficient in the presence of complement, 3 we thought to develop a more specific system for triggering eosinophil adhesion and subsequent cytolysis. Stimulation of eosinophils with IVIG plus iC3b, the latter known to be a ligand for complement receptor 3 (CR3), significantly induced cell death within 1 hour of adhesion (Fig 1, A, lower right panel) . The type of cell death corresponded morphologically to that induced by means of adhesion to glass coverslips because of reduced exposure to FCS (Fig  1, A, upper left panel) . Subsequently, we quantified cell death by using live cell imaging (Fig 1, B) . Interestingly, eosinophil death was accelerated in the presence of IL-5 (Fig 1, B, left panel) . In contrast, IVIG alone, iC3b alone, or 1% BSA did not induce cell death. TEM showed the hallmarks of cytolysis: loss of plasma membrane integrity and nuclear condensation accompanied by expulsion of intact single granules, resulting in the presence of cfegs (Fig 1, B , right panels). 10 As expected, blocking of CD18 with F(ab9) 2 fragments of an anti-CD18 antibody prevented cell spreading (Fig 1, C) , development of vacuolization (Fig 1, D) , and cell death (Fig 1, E) , confirming that this form of cytolysis can be specifically initiated through CR3. It should be noted that blocking CD18 also prevented eosinophil death induced by adhesion as a result of culturing the cells in medium with low FCS content (0.5% FCS, data not shown). To use a specific death trigger, however, in all subsequent experiments, we induced eosinophil cytolysis with IVIG plus iC3b in medium supplemented with 5% FCS.
Eosinophil vacuolization precedes cytolysis and occurs also under in vivo conditions
To investigate the morphologic changes associated with eosinophil cytolysis in single cells in a time-dependent manner, we followed a total of 100 eosinophils from 3 independent healthy volunteers using live cell imaging over a time period of 2 hours of continuous stimulation with IVIG plus iC3b (see Fig E1 and associated Video E1 in this article's Online Repository at www. jacionline.org). Eosinophils were stained with calcein-AM, Hoechst 33342, and ethidium bromide. Within 15 minutes of stimulation, we observed vacuolization in 56% 6 9% of the spread eosinophils, without cells having become ethidium bromide positive. The remaining cells detached from the surface and remained viable over the entire observation period. Moreover, 98.1% 6 3.3% of the vacuolated eosinophils finally underwent cytolysis within a time period of 2 hours (see Fig E1 and associated Video E1). These experiments emphasize an absolute requirement for adhesion and subsequent cell spreading for induction of vacuolization and cytolysis in eosinophils. Taken together, although spreading after adhesion is a reversible process, vacuolization is an early morphologic sign for subsequent cytolysis, at least in the setting of continuous eosinophil activation, because it occurred under these in vitro conditions.
To obtain evidence for possible in vivo relevance of the findings described above, we analyzed morphologic features of eosinophils from healthy donors and patients with HES. 21, 22 The patients with HES showed no evidence of eosinophilic leukemia and mostly had skin symptoms. Numbers of vacuolated eosinophils were much higher in patients with HES compared with healthy donors, both in blood (see Fig E2, A, upper panels, in this article's Online Repository at www.jacionline.org) and after eosinophil isolation (see Fig E2, A, lower panels) . Furthermore, in eosinophilic tissues we observed not only vacuolated eosinophils (arrows) but also nuclear disintegration (empty arrowhead) and cfegs (rhombus; see Fig E2, B) , suggesting that vacuolated eosinophils could proceed to cytolysis also under in vivo conditions. We have quantified the numbers of vacuolated eosinophils in a relatively large cohort of patients with different eosinophilic skin diseases. Vacuolization ranged between 0% and 44%. In contrast, eosinophils physiologically infiltrating the duodenum were vacuolated only rarely (see Fig E3 in this article' s Online Repository at www.jacionline.org).
Considering the role of adhesion in the process of cytolysis and the observation of vacuolated and cytolytic eosinophils in eosinophilic tissues, we addressed the question of whether cytolysis can develop within the bloodstream at sites of potential extravasation. IL-5-primed eosinophils were added to monolayers of IL-1b-primed human dermal endothelial cells. 23 Morphologic changes were followed by using live microscopy over a time period of 1 hour. Similar to IVIG plus iC3b-activated eosinophils, we observed rapid adhesion, spreading, and vacuolization in a subpopulation of IL-5-primed eosinophils (see Fig E2,  C) . However, the majority of eosinophils detached and remained viable under these in vitro conditions.
Eosinophil vacuolization results from granules fusion and depends on increased production of ROS Using TEM, we addressed the question of the origin of cytoplasmic vacuolization observed with live cell imaging. Granules of unstimulated eosinophils are characterized by an electron-dense crystalline core surrounded by a less electrondense matrix (see Fig E4, A, upper panels, g, in this article's Online Repository at www.jacionline.org). Eosinophil granules exhibited a prominent loss of both matrix and core density within 5 minutes after adhesion (see Fig E4, A, upper panels, hg) . Sombrero vesicles were found adjacent to these hypodense granules (see Fig E4, A, upper panels, sVES), implying ongoing piecemeal degranulation (PMD). 24 Furthermore, fusion of hypodense granules to large convolutes with beginning vacuolization (see Fig E4, A, upper panels, arrowheads) and subsequent dissolution of the vacuole content (see Fig E4, A, middle panels) were observed. Vacuoles were surrounded by a single membrane, which lost its integrity before nuclear or plasma membrane changes were detected (see Fig E4, A, lower panels) .
Using immunofluorescence, we detected EPX in beginning vacuoles on 5 minutes of adhesion, supporting the assumption that they originate from granules (see Fig E4, B) . TEM images did not allow a conclusive answer to the question of whether degranulation occurred out of or into the vacuoles. We addressed this question by using immunofluorescence and observed that the margins of vacuoles could be stained with a cell membrane dye (see Fig E4, C) , suggesting that the vacuoles might represent intracellular degranulation tunnels with access to the cell surface.
We also noticed that eosinophils release DNA within 5 minutes after IVIG plus iC3b-mediated adhesion. The released DNA could be stained with MitoSOX (stains DNA in the presence of ROS, such as mitochondrial DNA), suggesting that such stimulation results in the generation of extracellular DNA traps in which the DNA scaffold contains mitochondrial DNA (see Fig  E4, D) . 14 We next addressed molecular signaling events responsible for vacuolization and subsequent eosinophil cytolysis. We measured the production of ROS in IVIG plus iC3b-adherent eosinophils over a period of 1 hour and observed a significant increase within 15 minutes after CR3 activation (Fig 2, A) . PMA stimulation was used as a positive control in these experiments. In eosinophils ROS are mainly produced by the inducible NADPH oxidase system, which can be blocked with DPI.
14 Interestingly, DPI (1 mmol/L) not only reduced ROS production but also completely blocked cytoplasmic vacuolization (Fig 2,  B) and cytolysis (Fig 2, C) , suggesting that increased ROS production is required for these CR3-mediated cellular responses. Single-cell analysis with time-lapse automated fluorescence microscopy confirmed that only eosinophils generating high levels of ROS underwent subsequent vacuolization and cell death (see Fig E5 and associated Video E2 in this article's Online Repository at www.jacionline.org). In contrast, both increased ROS production and cytoplasmic vacuolization were unaffected by pharmacologic inactivation of caspases with a pancaspase inhibitor (z-VAD) (Fig 2, A and B) .
CR3 mediates activation of the RIPK3-MLKL pathway, which is required for increased ROS production and cytolysis
Because IVIG plus iC3b-mediated death was caspase independent and exhibited a necrotic phenotype, we investigated the possibility that the eosinophil cytolysis we observed might represent necroptosis, a type of death characterized by activation of the RIPK3-MLKL pathway. 13 Freshly isolated eosinophils exhibited no evidence of MLKL phosphorylation, suggesting that this essential effector protein in the cell death pathway downstream of RIPK3 was not activated at this time. 17, 18 In contrast, we observed phospho-MLKL signals as early as 5 minutes after activation with IVIG plus iC3b. Between 5 and 15 minutes after stimulation, the number of phospho-MLKL 1 eosinophils increased up to 21% (Fig 3, A) , indicating activation of the RIPK3-MLKL pathway. Moreover, we observed strong phospho-MLKL expression in 30% to 60% of infiltrating tissue eosinophils in biopsy specimens from patients with eosinophilic diseases (Fig 3, B) , suggesting that this pathway is also activated in inflammatory eosinophils under in vivo conditions.
To test whether the RIPK3-MLKL pathway is required for the IVIG plus iC3b-mediated eosinophil cytolysis, we used a pharmacologic approach. Inhibition of RIPK3 by GSK9872 or GSK9843 25 significantly reduced ROS production (Fig 4, A) and prevented vacuolization (Fig 4, B) and cell death (Fig 4, C) . Similarly, treatment of eosinophils with GW806742X 26 for pharmacologic inactivation of MLKL also reduced ROS production and blocked cell death (Fig 4) . The effects of GSK9843, GSK9872, and GW806742X were concentration dependent, and halfmaximal inhibitory concentration values for these inhibitors were in the micromolar range, as previously reported (see Fig  E6 in this article's Online Repository at www.jacionline.org). 25 Inhibition of RIPK1 by Nec-1 27 had no effect on IVIG plus iC3b-mediated ROS production and vacuolization (Fig 4, A and  B) . However, we noticed a minor but significant inhibitory effect on eosinophil death (Fig 4, C, and see Fig E6, B) . Based on these data, we conclude that RIPK3 and MLKL are involved in eosinophil cytolysis and that their activation occurs proximal to ROS production. In contrast, RIPK1 appears to play no role or only a minor role.
Because autocrine TNF-a is required for necroptosis induction in some cell lines 28 and because of our observation of early degranulation events (presence of sombrero vesicles, see Fig E4,  A) , we next investigated whether this requirement also applies for IVIG plus iC3b-mediated eosinophil death. The addition of neutralizing anti-TNF-a mAb to the culture medium had no effect in our system (see Fig E7 in this article' s Online Repository at www.jacionline.org). Moreover, blocking TNFR1 or TNFR2 by anti-TNFR1 or anti-TNFR2 mAbs 29 also did not prevent the eosinophil death induced by IVIG plus iC3b (see Fig  E7) . We were also unable to detect TNF-a in supernatants of 2-hour IVIG plus iC3b-stimulated eosinophils (data not shown). Thus we obtained no evidence for any role of autocrine TNF-a in the cell death pathway triggered by IVIG plus iC3b in eosinophils. p38 mitogen-activated protein kinase and phosphatidylinositol 39-kinase activation depends on activation of the RIPK3-MLKL pathway and is required for increased ROS production and cytolysis
It had previously been reported that increased ROS production by the NADPH oxidase requires p38 mitogen-activated protein kinase (MAPK) and phosphatidylinositol 39-kinase (PI3K) activation in neutrophils. 15 Therefore we pharmacologically blocked p38 MAPK with PD169316 and PI3K with wortmannin, observing markedly reduced ROS production (Fig 5, A) and vacuolization (Fig 5, B) and a corresponding reduction in cell death (Fig 5, C) by IVIG plus iC3b-activated eosinophils, suggesting that both p38 MAPK and PI3K are critical for eosinophil cytolysis. To directly analyze p38 MAPK in IVIG plus iC3b-activated eosinophils, we performed immunoblotting experiments, although this approach did not allow us to follow single eosinophils. After 15 minutes of activation, phosphorylation of p38 MAPK and MAPKAP kinase 2 (MK2; a direct target of p38) 30 was increased compared with that in unstimulated cells (Fig 5,  D) . To examine the possibility that the RIPK3-MLKL pathway is required for activation of p38 MAPK after IVIG plus iC3b stimulation in eosinophils, we again blocked RIPK1, RIPK3, and MLKL using pharmacologic inhibitors in these experiments.
Both inactivation of RIPK3 and MLKL prevented or reduced phosphorylation of both p38 and MK2, suggesting that p38 activation had been blocked under these conditions (Fig 5, D) . In contrast, Nec-1 treatment resulted in no p38 inhibition. Moreover, wortmannin blocked p38 activation, suggesting that PI3K activation is also proximal to p38 activation (Fig 5, D) . To confirm that the RIPK3-MLKL pathway is indeed proximal to p38, PI3K, and NADPH oxidase activation, we analyzed MLKL phosphorylation FIG 5 . Cytoplasmic vacuolization and cytolysis of eosinophils requires an active p38 MAPK pathway distal from MLKL. A, ROS production by IVIG plus iC3b-stimulated eosinophils was analyzed in a time-dependent manner by using a DHR oxidation assay. PMA was used as a positive control, and wortmannin (100 nmol/L) and PD169316 (10 mmol/L) were used to block PI3K and p38 MAPK, respectively. Both inhibitors inhibited ROS production. Data are representative of 3 independent experiments. B, Wortmannin and PD169316 prevented cytoplasmic vacuolization as quantified 15 minutes after initiation of IVIG plus iC3b stimulation. Values are means 6 SEMs. ***P < .001 (n 5 3). C, Wortmannin and PD169316 prevented eosinophil death as quantified 1 hour after initiation of IVIG plus iC3b stimulation. Values are means 6 SEMs. ***P < .001 and ****P < .0001 (n 5 3). D, Eosinophils were cultured in the presence and absence of PD169316 (10 mmol/L), wortmannin (100 nmol/L), Nec-1 (25 mmol/L), GSK9843 (50 mmol/L), GSK9872 (10 mmol/L), or GW806742X (5 mmol/L) and subsequently stimulated with IVIG plus iC3b for 15 minutes. Cell lysates were analyzed by means of immunoblotting for phosphorylated Thr180/Tyr182 p38 and phosphorylated Thr334 MK2. p38 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein levels were analyzed as loading controls. Representative immunoblots are shown (n > _ 3). E, Eosinophil lysates were analyzed by means of immunoblotting for RIPK3, RIPK1, and MLKL expression. Levels were compared with neutrophils and Jurkat T cells. GAPDH protein levels were analyzed as loading controls. Representative immunoblots are shown (n > _ 3).
FIG 4.
Cytoplasmic vacuolization and cytolysis of eosinophils require a functionally intact RIPK3-MLKL pathway. A, ROS production by IVIG plus iC3b-stimulated eosinophils was analyzed in a time-dependent manner by using a DHR oxidation assay. PMA was used as a positive control. Several pharmacologic blockers of the RIPK3-MLKL pathway were shown to inhibit ROS production. Data are representative of 3 independent experiments. B, GSK9872, GSK9843, and GW806742X, but not Nec-1, prevented cytoplasmic vacuolization as quantified 15 minutes after the initiation of IVIG plus iC3b stimulation. Values are means 6 SEMs. ***P < .001 (n 5 4). ns, Not significant. C, GSK9872, GSK9843, and GW806742X prevented eosinophil death as quantified 1 hour after the initiation of IVIG plus iC3b stimulation. In contrast, Nec-1 had much less inhibitory activity on eosinophil death. Values are means 6 SEMs. **P < .01 and ***P < .001 (n 5 3).
in the presence of PD169316, wortmannin, and DPI. None of these inhibitors was able to prevent MLKL activation (see Fig  E8 in this article' s Online Repository at www.jacionline.org).
Because Nec-1 inhibition did not markedly block eosinophil cytolysis, we analyzed the expression of RIPK1, RIPK3, and MLKL using immunoblotting. Although RIPK3 and MLKL were clearly detectable in eosinophils, the expression of RIPK1 was low or undetectable. Similarly, RIPK1 expression was also low in neutrophils compared with that in Jurkat cells (Fig 5, E) . Taken together, one concludes that the RIPK3-MLKL pathway acts proximal to p38 MAPK and PI3K, both of which are required for increased ROS production and eosinophil cytolysis.
Induction of mechanistic target of rapamycindependent autophagy rescues eosinophils from IVIG plus iC3b-induced cytolysis Autophagosomes engulfing cytosolic material, the hallmark of autophagy, could be detected in eosinophils within the process of cytolysis (see Fig E9, arrowheads, in this article's Online Repository at www.jacionline.org). Autophagosome formation was also monitored by using AUTOdot, a monodansylcadaverine-like lysosomotropic agent that detects autophagosome formation through an ion-trapping mechanism and interaction with lipids concentrated in the autophagosome membrane. 31 We observed enhanced AUTOdot fluorescence in eosinophils undergoing cytolysis, suggesting increased autophagosome formation in these cells (Fig 6, A) . To investigate whether activation of autophagy during cytolysis was part of the cell death pathway or rather a compensatory prosurvival strategy of the eosinophil, we used rapamycin, a mechanistic target of rapamycin (mTOR) inhibitor, to induce autophagy before adhesion. Pretreating eosinophils with rapamycin resulted in increased autophagic activity (Fig 6, A) together with a significant reduction of vacuolization (Fig 6, B) and cell death (Fig 6, C) . These data suggest that autophagy plays a counterregulatory role in the adhesion-induced cytolysis of eosinophils.
DISCUSSION
Thus far, evidence for necroptosis in human diseases has been obtained only for epithelial cells of the liver, intestine, and skin. 13 In the present article we provide evidence that adhesion can activate the RIPK3-MLKL pathway in eosinophils under inflammatory conditions both in vitro and in vivo. Moreover, pharmacologic inhibition of RIPK3 and MLKL blocked the death pathway triggered by CR3, suggesting that the cytolysis of eosinophils observed under these conditions is in fact a necroptosis. We also report that cytoplasmic vacuolization is an irreversible death event for eosinophils undergoing cytolysis, at least under in vitro conditions of continuous stimulation with IVIG plus iC3b. A recent report demonstrated a correlation between eosinophil vacuolization, the presence of cfegs, and cytolysis with the severity of asthma exacerbations in children, 9 suggesting that eosinophil cytolysis/necroptosis might additionally trigger the inflammatory responses. Therefore it is important to better understand the mechanism for this still largely unknown cell death pathway in eosinophils.
Necroptosis can be induced by death receptors, Toll-like receptors, and intracellular RNA and DNA sensors. 13 Here we provide evidence that CR3 activation on eosinophils can also result in necroptosis. Interestingly, increased activation of b 2 -integrins on eosinophils has been observed in asthmatic patients after allergen challenge, 32 pointing to the likelihood that the death mechanism described here also occurs under in vivo conditions. Pharmacologic inactivation of RIPK3 with 2 different inhibitors completely prevented ROS production and eosinophil cytolysis triggered by CR3 in vitro. In contrast, inhibition of RIPK1 had a minor effect only, perhaps as a consequence of low expression levels. It should be noted that necroptosis has also been described in the absence of RIPK1. 13, [33] [34] [35] In TNFR1-induced necroptosis, the necrosome, which is defined as the complex containing RIPK1 and RIPK3, plays a key role in initiation of necroptosis. 13, 36 Using neutralizing and blocking antibodies, we obtained no evidence that TNF-a mediates CR3-triggered eosinophil cytolysis. However, we cannot exclude that activation of TNFR1 in the absence of its ligand is a consequence of adhesion. Moreover, a previous report suggested that activation of CR3 with soluble intercellular adhesion molecule 1 prolonged eosinophil survival. 37 The IVIG plus iC3b-mediated death shown here strictly required adhesion. Therefore it is possible that the strength of CR3 activation determines the functional response of the cell. Clearly, the mechanism of RIPK3 activation by CR3 in eosinophils remains to be further investigated.
Pharmacologic inactivation of MLKL, which is known as a pseudokinase involved in executing cell death in necroptosis downstream of RIPK3, 26 completely prevented CR3-mediated ROS production in eosinophils and their subsequent cytolysis. Recent studies have suggested that RIPK3-mediated activation of MLKL leads to its binding at cellular membranes, thereby triggering ion fluxes. 17, 26, 38 However, in eosinophil cytolysis MLKL, in collaboration with RIPK3, was required to activate p38 MAPK and NADPH oxidase activation. A connection between MLKL and downstream effectors had been suggested previously. For instance, it has been shown that RIPK3 does not trigger phosphorylation of the mitochondrial protein phosphatase PGMA5 in the absence of MLKL. 39 Moreover, overexpression of MLKL has been reported to activate c-Jun N-terminal kinase. 40 MLKL has also been shown to contribute to inflammasome activation, 41 further supporting the idea that it might be involved in signaling pathways. Therefore MLKL should be seen not only as a necroptosis executor protein but also as an adaptor protein for necrosis signaling.
Eosinophil cytolysis and necrosis-like eosinophil death, respectively, have also been reported after treatment with calcium ionophores 12, 42 or ligation of sialic acid-binding immunoglobulin-like lectin 8. 43, 44 Whether the RIPK3-MLKL signaling pathway mediates eosinophil death under these conditions as well remains to be determined. On the other hand, the same critical role of the NADPH oxidase for eosinophil death had been demonstrated in these previous reports, 12, 43, 44 suggesting that the molecular mechanisms overlap, at least partially. It should be noted that ROS-dependent cytoplasmic vacuolization has also been described in GM-CSF-primed and CD44-activated neutrophils as a morphologic feature of the programmed necrotic cell death pathway. 15 Therefore it has been suggested that this previously described caspase-independent neutrophil death represents necroptosis as well. 45 Increased ROS production can be expected to bring about the induction of autophagy, 46 as we have observed in this study. The removal of irreversibly damaged biomolecules is likely to be a process that can support eosinophil survival. Clearly, ROS are likely to be involved in the permeabilization of granules 15 and, as shown in this study, of vacuoles (see Fig E4) , but the exact mechanism of how necrosis occurs under these circumstances remains to be investigated.
We observed PMD in eosinophils that subsequently underwent vacuolization and cytolysis. Previous morphologic studies addressing the origin of cytoplasmic vacuolization resulted in 2 opposing viewpoints: vacuoles can result from PMD 47 or they can represent 3-dimensional degranulation tunnels. 4 Our findings suggest that these previous observations might be interconnected: the first observation would lead to hypodense granules and a larger fusion product, which finally connects to the plasma membrane. In consequence, an increased cell surface available for degranulation is achieved. Moreover, we hypothesize that the degranulation tunnels of several eosinophils adherent to a pathogen might lead to accumulation of cytotoxic agents at these loci, resulting in more efficient destruction of the target as opposed to simple degranulation. Morphologic observations of vacuolated eosinophils showed initial loss of plasma membrane integrity at the site of the vacuole/tunnel membrane, suggesting high cytotoxicity at these loci. It is possible that the loss of plasma membrane integrity contributes to the death process: as analyzed by using single-cell live microscopy, we observed that essentially all vacuolated eosinophils underwent lysis within 2 hours. Whether MLKL, in addition to its role as an adaptor protein for signal transduction, also participates in the process of plasma membrane permeabilization remains to be investigated.
As assessed by using TEM and fluorescence analyses, we observed autophagosomes in eosinophils undergoing cytolysis. Interestingly, pharmacologic inhibition of mTOR by rapamycin not only increased autophagy but also, at least partially, prevented cell death in IVIG plus iC3b-activated eosinophils. Therefore eosinophil cytolysis does not appear to represent autophagic cell death; instead, the induction of autophagy seems to be an attempt to maintain viability. These data support previously published work suggesting that autophagy and/or autophagy-related proteins can modify necroptosis. For instance, autophagy has been shown to promote RIPK1 degradation, 48 and autophagy-related protein 5 is able to activate necrosome formation on the autophagosome. 49 Although the mechanism of how autophagy counterregulates eosinophil cytolysis remains to be investigated, it seems reasonable that preventing proinflammatory cell death in the eosinophilic inflammatory response could represent a new therapeutic strategy in diseases associated with eosinophil-mediated immunopathology, such as bronchial asthma and atopic dermatitis.
